Cargando…

Costs and Cost-Effectiveness of Hypertension Screening and Treatment in Adults with Hypertension in Rural Nigeria in the Context of a Health Insurance Program

BACKGROUND: High blood pressure is a leading risk factor for death and disability in sub-Saharan Africa (SSA). We evaluated the costs and cost-effectiveness of hypertension care provided within the Kwara State Health Insurance (KSHI) program in rural Nigeria. METHODS: A Markov model was developed to...

Descripción completa

Detalles Bibliográficos
Autores principales:	Rosendaal, Nicole T. A., Hendriks, Marleen E., Verhagen, Mark D., Bolarinwa, Oladimeji A., Sanya, Emmanuel O., Kolo, Philip M., Adenusi, Peju, Agbede, Kayode, van Eck, Diederik, Tan, Siok Swan, Akande, Tanimola M., Redekop, William, Schultsz, Constance, Gomez, Gabriela B.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Public Library of Science 2016
Materias:	Research Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4922631/ https://www.ncbi.nlm.nih.gov/pubmed/27348310 http://dx.doi.org/10.1371/journal.pone.0157925

Ejemplares similares

Improving Maternal Care through a State-Wide Health Insurance Program: A Cost and Cost-Effectiveness Study in Rural Nigeria
por: Gomez, Gabriela B., et al.
Publicado: (2015)

Step-by-step guideline for disease-specific costing studies in low- and middle-income countries: a mixed methodology
por: Hendriks, Marleen E., et al.
Publicado: (2014)

Perceptions of inhibitors and facilitators for adhering to hypertension treatment among insured patients in rural Nigeria: a qualitative study
por: Odusola, Aina O, et al.
Publicado: (2014)

Cardiovascular disease prevention in rural Nigeria in the context of a community based health insurance scheme: QUality Improvement Cardiovascular care Kwara-I (QUICK-I)
por: Hendriks, Marleen, et al.
Publicado: (2011)

Development and evaluation of a patient centered cardiovascular health education program for insured patients in rural Nigeria (QUICK - II)
por: Odusola, Aina Olufemi, et al.
Publicado: (2011)

Enablers and barriers for implementing high-quality hypertension care in a rural primary care setting in Nigeria: perspectives of primary care staff and health insurance managers
por: Odusola, Aina O., et al.
Publicado: (2016)

Mapping knowledge management resources of maternal, newborn and child health (MNCH) among people living in rural and urban settings of Ilorin, Nigeria
por: Bolarinwa, Oladimeji Akeem, et al.
Publicado: (2014)

What medicines do households keep in their cabinets? Understanding the possession and use of medicines at home and the role of health insurance in Nigeria
por: Shobiye, Hezekiah Olayinka, et al.
Publicado: (2021)

Effects of a temporary suspension of community-based health insurance in Kwara State, North-Central, Nigeria
por: Bolarinwa, Oladimeji Akeem, et al.
Publicado: (2022)

Ownership and utilisation of long lasting insecticide treated nets following free distribution campaign in South West Nigeria
por: Aderibigbe, Sunday Adedeji, et al.
Publicado: (2014)

Hypertension in Sub-Saharan Africa: Cross-Sectional Surveys in Four Rural and Urban Communities
por: Hendriks, Marleen E., et al.
Publicado: (2012)

The effect of health insurance and health facility-upgrades on hospital deliveries in rural Nigeria: a controlled interrupted time-series study
por: Brals, Daniëlla, et al.
Publicado: (2017)

Normotensive offspring of hypertensive Nigerians have increased Left ventricular mass and abnormal geometric patterns
por: Kolo, Philip, et al.
Publicado: (2012)

Direct Costs of Hypertension Treatment in Iran
por: Zamandi, Mahmoud, et al.
Publicado: (2023)

Pharmacy-based hypertension care employing mHealth in Lagos, Nigeria – a mixed methods feasibility study
por: Nelissen, Heleen E., et al.
Publicado: (2018)

Left Ventricular Hypertrophy Is Associated with Diastolic Filling Alterations in Normotensive Offspring of Hypertensive Nigerians
por: Kolo, P. M., et al.
Publicado: (2012)

Effectiveness, safety and cost of drug substitution in hypertension
por: Johnston, Atholl, et al.
Publicado: (2010)

Cost-effectiveness of digital therapeutics for essential hypertension
por: Nomura, Akihiro, et al.
Publicado: (2022)

Cost-Effectiveness Analysis of Personalized Hypertension Prevention
por: Wang, Sen-Te, et al.
Publicado: (2023)

Correction: Costs and Cost-Effectiveness of Hypertension Screening and Treatment in Adults with Hypertension in Rural Nigeria in the Context of a Health Insurance Program
Publicado: (2016)

Hypertension-Related Admissions and Outcome in a Tertiary Hospital in Northeast Nigeria
por: Kolo, P. M., et al.
Publicado: (2012)

Update of the Dutch manual for costing studies in health care
por: Kanters, Tim A., et al.
Publicado: (2017)

A noticeable difference? Productivity costs related to paid and unpaid work in economic evaluations on expensive drugs
por: Krol, Marieke, et al.
Publicado: (2015)

Cost-consequence analysis of remifentanil-based analgo-sedation vs. conventional analgesia and sedation for patients on mechanical ventilation in the Netherlands
por: Al, Maiwenn J, et al.
Publicado: (2010)

Cost-effectiveness of pharmacist care for managing hypertension in Canada
por: Marra, Carlo, et al.
Publicado: (2017)

Health-care costs of losartan and candesartan in the primary treatment of hypertension
por: Henriksson, M, et al.
Publicado: (2011)

Current trends in treatment of hypertension in Karachi and cost minimization possibilities
por: Hussain, Izhar M., et al.
Publicado: (2015)

The Hospitalization Costs of Diabetes and Hypertension Complications in Zimbabwe: Estimations and Correlations
por: Mutowo, Mutsa P., et al.
Publicado: (2016)

A global perspective on the costs of hypertension: a systematic review
por: Wierzejska, Ewelina, et al.
Publicado: (2020)

Antihypertensive Prescribing for Uncomplicated, Incident Hypertension: Opportunities for Cost Savings
por: Quinn, Amity E., et al.
Publicado: (2021)

Cost-Effectiveness of Pharmacist Prescribing for Managing Hypertension in the United States
por: Dixon, Dave L., et al.
Publicado: (2023)

Digital hypertension management: clinical and cost outcomes of a pilot implementation of the OMRON hypertension management platform
por: Holmstrand, Ericka C., et al.
Publicado: (2023)

The Cost-Effectiveness of Low-Cost Essential Antihypertensive Medicines for Hypertension Control in China: A Modelling Study
por: Gu, Dongfeng, et al.
Publicado: (2015)

Direct costs of hypertensive patients admitted to hospital in Vietnam– a bottom-up micro-costing analysis
por: Nguyen, Thi-Phuong-Lan, et al.
Publicado: (2014)

Reducing costly falls after total knee arthroplasty
por: Bolarinwa, Surajudeen Adebola, et al.
Publicado: (2018)

Cost-Effectiveness of Masked Hypertension Screening and Treatment in US Adults With Suspected Masked Hypertension: A Simulation Study
por: Green, Matthew B, et al.
Publicado: (2022)

Cost-utility analysis of a national project to reduce hypertension in Israel
por: Yosefy, Chaim, et al.
Publicado: (2007)

Cost of outpatient hypertension pharmacotherapy: comparative study between Bulgaria and Serbia
por: Ivanova, Anna, et al.
Publicado: (2009)

The managed hypertensive: the costs of blood pressure control in a Nigerian town
por: Ilesanmi, Olayinka Stephen, et al.
Publicado: (2012)

Cost-effectiveness of candesartan versus losartan in the primary preventive treatment of hypertension
por: Granström, Ola, et al.
Publicado: (2012)

Cannot write session to /tmp/vufind_sessions/sess_bj9aggi8fom7n4uetmqp5s8r4k